Brand Overview
Zeroid is a Korean medical skincare brand developed by Neopharm, with its name derived from “Zero Steroid” to emphasize non-steroidal yet powerful formulations. The brand operated primarily in the medical channel, establishing distribution in approximately 70% of dermatology clinics and 80% of pediatric practices nationwide, as well as hospitals across South Korea. Around 2024, Zeroid expanded to general retail via Olive Young, making dermatologist-recommended products widely accessible.
The brand’s core technology centers on Multi Lamellar Emulsion (MLE), Neopharm’s proprietary skin barrier technology that creates three-dimensional structures identical to natural skin architecture. This approach aims to restore and strengthen the skin’s inherent barrier function, particularly for dry and sensitive skin conditions. Zeroid also incorporates Defensamide, a compound designed to enhance skin defense against various environmental stressors and maintain healthy barrier integrity through clinical formulation development.
Zeroid’s approach combines medical expertise and research-driven innovation, addressing specific skin concerns with targeted product lines. This clinical foundation sets the brand apart in the competitive Korean skincare market, leveraging professional endorsement and evidence-based science to build consumer trust.
Signature Ingredients
- MLE Formula®: A patented formula unique to Neopharm, MLE Formula® uses Ceramide-9S, phytosterols, and stearic acid to mimic the skin’s natural lamellar structure. It reinforces the skin barrier, protects sensitive and dry skin, and enhances moisture retention for healthier, more resilient skin.
- Defensamide™️: This ingredient boosts the production of antimicrobial peptides (AMPs), natural antibiotic elements in the body, to help prevent bacterial, viral, and fungal infections on the skin. By strengthening the skin’s innate defense system without promoting antibiotic-resistant bacteria, it supports long-term skin health and helps maintain overall skin balance.